דטסקאן

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

IOFLUPANE

Disponibil de la:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

Codul ATC:

V09AB03

Forma farmaceutică:

תמיסה להזרקה

Compoziție:

IOFLUPANE 74 MBQ/ML

Calea de administrare:

תוך-ורידי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

GE HEALTHCARE B.V., THE NETHERLAND

Grupul Terapeutică:

OTHER DOPAMINERGIC AGENTS

Zonă Terapeutică:

IODINE IOFLUPANE (123I)

Indicații terapeutice:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Data de autorizare:

2014-11-30